000			02115 a2200589 4500
005			20250515163220.0
264		0	_c20121227
008			201212s 0 0 eng d
022			_a1440-1681
024	7		_a10.1111/j.1440-1681.2009.05166.x _2doi
040			_aNLM _beng _cNLM
100	1		_aPovlsen, J A
245	0	0	_aCardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats. _h[electronic resource]
260			_bClinical and experimental pharmacology & physiology _cSep 2009
300			_a892-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBlotting, Western
650	0	4	_aCardiotonic Agents _xpharmacology
650	0	4	_aDiabetes Complications _xetiology
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aExcitatory Amino Acid Transporter 1 _xgenetics
650	0	4	_aExcitatory Amino Acid Transporter 3 _xgenetics
650	0	4	_aGlutamic Acid _xpharmacology
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aMale
650	0	4	_aMitochondria, Heart _xdrug effects
650	0	4	_aMyocardial Infarction _xetiology
650	0	4	_aMyocardial Reperfusion Injury _xetiology
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aObesity _xcomplications
650	0	4	_aPerfusion
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Inbred WKY
650	0	4	_aRats, Zucker
650	0	4	_aSarcolemma _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aVentricular Function, Left _xdrug effects
700	1		_aLøfgren, B
700	1		_aRasmussen, L E
700	1		_aNielsen, J M
700	1		_aNørregaard, R
700	1		_aKristiansen, S B
700	1		_aBøtker, H E
700	1		_aNielsen, T T
773	0		_tClinical and experimental pharmacology & physiology _gvol. 36 _gno. 9 _gp. 892-8
856	4	0	_uhttps://doi.org/10.1111/j.1440-1681.2009.05166.x _zAvailable from publisher's website
999			_c18736807 _d18736807